全文获取类型
收费全文 | 9618篇 |
免费 | 601篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 299篇 |
妇产科学 | 167篇 |
基础医学 | 1500篇 |
口腔科学 | 103篇 |
临床医学 | 860篇 |
内科学 | 2244篇 |
皮肤病学 | 181篇 |
神经病学 | 961篇 |
特种医学 | 292篇 |
外国民族医学 | 1篇 |
外科学 | 1330篇 |
综合类 | 62篇 |
一般理论 | 4篇 |
预防医学 | 660篇 |
眼科学 | 107篇 |
药学 | 686篇 |
中国医学 | 7篇 |
肿瘤学 | 740篇 |
出版年
2023年 | 46篇 |
2022年 | 106篇 |
2021年 | 208篇 |
2020年 | 124篇 |
2019年 | 187篇 |
2018年 | 222篇 |
2017年 | 143篇 |
2016年 | 174篇 |
2015年 | 221篇 |
2014年 | 291篇 |
2013年 | 452篇 |
2012年 | 635篇 |
2011年 | 685篇 |
2010年 | 418篇 |
2009年 | 371篇 |
2008年 | 597篇 |
2007年 | 679篇 |
2006年 | 585篇 |
2005年 | 640篇 |
2004年 | 606篇 |
2003年 | 621篇 |
2002年 | 498篇 |
2001年 | 122篇 |
2000年 | 88篇 |
1999年 | 134篇 |
1998年 | 116篇 |
1997年 | 109篇 |
1996年 | 84篇 |
1995年 | 77篇 |
1994年 | 56篇 |
1993年 | 62篇 |
1992年 | 67篇 |
1991年 | 48篇 |
1990年 | 58篇 |
1989年 | 48篇 |
1988年 | 39篇 |
1987年 | 33篇 |
1986年 | 31篇 |
1985年 | 25篇 |
1984年 | 30篇 |
1983年 | 29篇 |
1982年 | 27篇 |
1981年 | 17篇 |
1980年 | 25篇 |
1979年 | 24篇 |
1978年 | 25篇 |
1974年 | 18篇 |
1973年 | 20篇 |
1932年 | 19篇 |
1931年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
3.
4.
5.
6.
Erythropoietin(EPO) is one of the most successful biopharmaceuticals in history and is used for treating anemia of different origins. However, it became clear that EPO could also work in a neuroprotective, antiapoptotic, antioxidative, angiogenetic and neurotropic way. It causes stimulation of cells to delay cell apoptosis, especially in the central nervous system. In rodent models of focal cerebral ischemia, EPO showed an impressive reduction of infarct size by 30% and improvement of neurobehavioral outcome by nearly 40%. A large animal model dealing with ischemia and reperfusion of the spinal cord showed that EPO could reduce the risk of spinal cord injury significantly. In addition, some clinical studies tested whether EPO works in real live clinical settings. One of the most promising studies showed the innocuousness and improvements in follow-up, outcome scales and in infarct size, of EPO-use in humans suffering from ischemic stroke. Another study ended unfortunately in a negative outcome and an increased overall death rate in the EPO group. The most possible reason was the involvement of patients undergoing simultaneously systemic thrombolysis with recombinant tissue plasminogen activator. An experimental study on rats demonstrated that administration of EPO might exacerbate tissue plasminogen activator-induced brain hemorrhage without reducing the ischemic brain damage. This case shows clearly how useful animal models can be to check negative side effects of a treatment before going into clinical trials. Other groups looked in human trials at the effects of EPO on the outcome after ischemic stroke, relation to circulating endothelial progenitor cells, aneurysmal subarachnoid hemorrhage, traumatic brain injury, hemoglobin transfusion thresholds and elective first-time coronary artery bypass surgery. Most of the results were positive, but are based mostly on small group sizes. However, some of the most neglected facts when focusing on experimental setups of ischemia of the central nervous system are issues like age and comorbidities. It might be extremely worthy to consider these points for future projects, because EPO might influence all these factors. 相似文献
7.
Prostatitis and male infertility are frequent disorders, and the role of prostatitis in male infertility has been under discussion for more than 30 years. Many researchers have shown relevant links between the two. Although a causal relationship has not been definitely demonstrated, increasing evidence shows that chronic prostatitis has a relevant negative impact on male fertility potential, at least in certain subgroups. In the following review, we focus on the present state of knowledge on the role of chronic prostatitis as an etiologic factor in male infertility. 相似文献
8.
Acetabular blood flow during Bernese periacetabular osteotomy: an intraoperative study using laser Doppler flowmetry. 总被引:2,自引:0,他引:2
Axel Hempfing Michael Leunig Hubert P. Ntzli Martin Beck Reinhold Ganz 《Journal of orthopaedic research》2003,21(6):1145-1150
BACKGROUND: The blood flow to the acetabular fragment is of some concern in juxtaarticular pelvic osteotomies used for the treatment of hip dysplasia. No direct measurements have determined the effect of the Bernese periacetabular osteotomy (PAO) on acetabular perfusion. METHODS: Acetabular perfusion was measured by means of laser Doppler flowmetry in 10 patients undergoing a PAO for symptomatic acetabular dysplasia. During the surgical procedure, the intraosseous high energy laser Doppler reliably depicts dynamic changes of small vessel blood flow. Measurements were performed after defined surgical steps to obtain sequential information on the blood perfusion of the acetabular fragment. RESULTS: After complete separation of the acetabular fragment, nine out of 10 patients had pulsatile signals, but the blood flow (BF) significantly decreased by 77%. Corrective positioning of the fragment induced no further drop of the BF signal but a loss of pulsatility in six patients. After a recovery period of about 30 min following preliminary fixation of the fragment, reestablishment of the pulsatile signal and an increase of the BF signal was seen. At termination of the surgical procedure, five out of eight patients, who could be followed throughout the whole procedure, showed a clear pulsatile signal in the supraacetabular area. Bleeding of the supraacetabular cancellous surface could be observed in all acetabula. CONCLUSION: Despite careful preservation of soft tissues during the surgical procedure, a significant reduction of the blood flow in the supraacetabular region has been observed. Nevertheless, a pulsatile signal in more than 60% of the fragments after fragment correction and an increasing signal during the recovery period showed ongoing blood perfusion indicating reversible changes in the measured supraacetabular area. All osteotomies healed within eight weeks without showing signs of necrosis during a minimum follow up of 1 year. 相似文献
9.
Alessia Pascale Marialaura Amadio Stefano Govoni Fiorenzo Battaini 《Pharmacological research》2007,55(6):560-569
The brain represents the primary centre for the regulation and control of all our body activities, receiving and interpreting sensory impulses and transmitting information to the periphery. Most importantly, it is also the seat of consciousness, thought, emotion and especially memory, being in fact able to encode, store and recall any information. Memory is really what makes possible so many of our complex cognitive functions, including communication and learning, and surely without memory, life would lose all of its glamour and purpose. Age-associated mental impairment can range in severity from forgetfulness at the border with pathology to dementia, such as in Alzheimer's disease. In recent years, one of the most relevant observations of research on brain aging relates to data indicating that age-related cognitive decline is not only due to neuronal loss, as previously thought; instead, scientists now believe that age-associated functional changes have more to do with the dysfunctions occurring over time. Within this context a prominent role is certainly played by signal transduction cascades which guarantee neuronal cell to elaborate coordinated responses to the multiple signals coming from the outside and to adapt itself to the environmental changes and requests. This review will focus the attention on protein kinase C pathway, with a particular interest on its activation process, and on the role of protein-lipid and protein-protein interactions to selectively localize the cellular responses. Furthermore, information is emerging and will be discussed on the possibility of mRNA stabilization through PKC activation. This review will also approach the issue on how alterations of these molecular cascades may have implications in physiological and pathological brain aging, such as Alzheimer's disease. 相似文献
10.
Pascale Jolliet Stéphane Nion Gwena?lle Allain-Veyrac L Tilloy-Fenart Dorothée Vanuxeem Vincent Berezowski Roméo Cecchelli 《Pharmacological research》2007,56(1):11-17
PURPOSE: The objective of the current study was to determine the ability of some antiemetic compounds to cross the blood-brain barrier (BBB) and thereby to determine possible side effects of compounds for the central nervous system (CNS). METHODS: We compared the brain penetration of some antiemetic compounds using an in vitro BBB model consisting in brain capillary endothelial cells co-cultured with primary rat glial cells. RESULTS: This study clearly demonstrated that the metopimazine metabolite, metopimazine acid, has a very low brain penetration, lower than metopimazine and even less than the other antiemetic compounds tested in this study. CONCLUSIONS: The poor brain penetration of metopimazine acid, metopimazine biodisponible form, seems very likely related to the clinically observed difference in therapeutic and safety profile. 相似文献